Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

London pre-open: Slightly higher start expected

Thu, 07th Apr 2016 07:08
(ShareCast News) - Stocks were expected to start the morning higher, tracking strong gains on Wall Street in the wake of the latest set of Federal Reserve meeting minutes which revealed deep divisions among the US central bank's rate-setters.The FTSE 100 was being called to start the day up by eight points or 0.13% from Wednesday's closing level of"The minutes of the March 16 FOMC meeting reveal that the Committee is now deeply, and almost evenly divided. The split reaches from the risks to the economic outlook and the interpretation of inflation expectations to the appropriate policy outlook. This great divide may be the reason why Chair Yellen felt in late March that she has to go in the offense and deliver a surprisingly dovish speech," Dr.Harm Bandholz, chief US economist at Unicredit Research said in a research note sent to clients.To take note of, overnight the US dollar fell back to a one-and-a-half-year low versus the Japanese yen.As of 08:31 BST it was trading 0.88% lower at 108.83, while the Shanghai Stock Exchange's Composite Index finished the session down by 0.54% to 3,034.052.Also overnight, the Dutch voted in a referendum to reject a mooted EU partnership deal with Ukraine which would see the removal of trade restrictions with the east European country, with a full 61.1% of those who cast their ballots saying they were against the initiative."Under the vote rules means [the referendum results mean] it will be very difficult for Dutch leaders and by implication, EU leaders to ignore it."That doesn't mean they won't try as the EU has form in this area," said Michael Hewson, chief market analyst at CMC Markets UK."As it is the outcome of yesterday's vote is likely to give a significant boost to the "Brexit" campaign here in the UK, and in that context the EU's response to it will need to be very carefully managed lest more fire is poured on the flames of populism, which is rippling out through Europe."Shire reassures shareholdersDrug maker Shire has reassured investors that it is confident, even with new rules from the US Treasury to block 'tax inversion' deals, that its takeover of US-based Baxalta will proceed as planned. "The combination of Shire and Baxalta is based on a strong strategic rationale to create the leading global biotechnology company focused on rare diseases," Shire said in a statement, adding that it expects to complete its proposed combination by mid-2016.Home furnishings retailer Dunelm reported total revenue for the third quarter increasing by 5.9%, with like-for-like growth, up 1.1%. Gross margin for the quarter was 90 basis points higher than the previous comparative period, with the board putting this down to improved stock management and the reduced cost of end of season product clearance.Fourth quarter sales at Marks & Spencer were up 1.9% in the fourth quarter as the food business outperformed the market but was again held back by weak clothing sales. New chief executive Steve Rowe said: "Although the sales decline in Clothing and Home was lower than last quarter, our performance remains unsatisfactory and there is still more we need to do."

Related News

LONDON MARKET CLOSE: Oil falls amid hoped for Trump peace deal backing
29 May 2026

LONDON MARKET CLOSE: Oil falls amid hoped for Trump peace deal backing

(Alliance News) - The FTSE 100 edged lower on Friday, as US President Donald Trump said he was now making a "final" decision on whether or not to stri...

LONDON MARKET MIDDAY: FTSE 100 rises but downgrades harm retail stocks
29 May 2026

LONDON MARKET MIDDAY: FTSE 100 rises but downgrades harm retail stocks

(Alliance News) - Stock prices in London were higher at midday on Friday, as investors awaited further news from the Middle East, while three FTSE 250...

WINNERS & LOSERS: Autotrader rebounds; Ocado jumps on Asda partnership
29 May 2026

WINNERS & LOSERS: Autotrader rebounds; Ocado jumps on Asda partnership

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Friday.

Shire News

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push
6 Sep 2019

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms ...

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt
14 Aug 2019

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus ma...

Takeda kicks off sale of Western European drugs - sources
17 Jul 2019

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders fo...

Japan's Takeda expects binding offers for Latam business by end of May -sources
16 May 2019

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by...

Nikkei snaps 7-day losing streak helped by China's stimulus hopes
15 May 2019

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform B...

Nikkei hobbled by trade worries, disappointing earnings
15 May 2019

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earn...

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal
14 May 2019

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers ...

Japan's Takeda expects annual loss on Shire deal
14 May 2019

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books cost...